Skip to content

Investigator

Artem Barski

DATIRIUM, LLC · funded by NIAID

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.2M

Summed across those awards.

First award
Mar 8, 2021

Latest Jan 6, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R41

    Bioinformatics pipeline for personalized diagnostics of transplant rejection

    $307k

    Jan 6, 2025NIAIDDATIRIUM, LLCNIH RePORTER · 11069619 (opens the source filing in a new tab)

  2. R41

    Bioinformatics pipeline for personalized diagnostics of transplant rejection

    $307k

    Jan 6, 2025NIAIDDATIRIUM, LLCNIH RePORTER · 11254890 (opens the source filing in a new tab)

  3. R01

    An experimentally-refined, dynamic gene regulatory network model of T-cell memory

    $633k

    Mar 8, 2021NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11042256 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources